Medicine & Life Sciences
Radiopharmaceuticals
100%
Radioisotopes
94%
Radioimmunotherapy
72%
Neoplasms
54%
Alpha Particles
50%
Radiation
41%
Single-Photon Emission-Computed Tomography
41%
Antibodies
41%
Therapeutics
37%
Bone Marrow
37%
Radiometry
32%
Prostate-Specific Antigen
29%
Kidney
27%
Liposomes
26%
Nuclear Medicine
25%
Thyroid Neoplasms
24%
Pharmacokinetics
22%
Technetium Tc 99m Dimercaptosuccinic Acid
22%
Prostatic Neoplasms
21%
Electrons
20%
Photons
20%
Relative Biological Effectiveness
19%
Pamphlets
19%
Pediatrics
19%
Monoclonal Antibodies
18%
Radioactivity
17%
Breast Neoplasms
17%
Single Photon Emission Computed Tomography Computed Tomography
16%
Membranes
16%
Radiotherapy
15%
Actinium-225
15%
Liver
14%
Radiobiology
14%
Positron-Emission Tomography
13%
ibritumomab tiuxetan
13%
Linear Energy Transfer
13%
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
12%
Neoplasm Metastasis
11%
Osteosarcoma
11%
lintuzumab
10%
Software
10%
Non-Hodgkin's Lymphoma
10%
Half-Life
10%
monoclonal antibody M195
9%
Fluorodeoxyglucose F18
9%
Spleen
9%
Nude Mice
9%
Heterografts
9%
N-(N-((S)-1,3-Dicarboxypropyl)carbamoyl)-4-(18F)fluorobenzyl-L-cysteine
9%